Bay Island Cell raises $19.6M series a
Bay Island Cell raised $19.6M in series a funding, announced on 11 July 2026, led by Shenzhen Capital Group, Songhe Capital, with participation from CoStone Capital, Orient Fortune Capital. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu. Bay Island Cell is based in China and currently at series a stage, operating in healthtech, deeptech.
Round details
| Company | Bay Island Cell |
| Stage | series a |
| Amount | $19.6M |
| Announced | 11 July 2026 |
| Lead | Shenzhen Capital Group, Songhe Capital |
| Participation | CoStone Capital, Orient Fortune Capital |
| Source | announcement ↗ |
Frequently asked questions
- How much did Bay Island Cell raise?
- Bay Island Cell raised $19.6M in its series-a round, announced 2026-07-11.
- Who invested in Bay Island Cell's series-a round?
- The round was led by Shenzhen Capital Group and Songhe Capital, with participation from CoStone Capital and Orient Fortune Capital.
- What does Bay Island Cell do?
- Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu.
Verified 11 July 2026 · Sources: public filings